09/23/2024 3:33 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 3:30 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 3:23 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form DEF 14A | |
08/06/2024 3:47 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 5:33 PM | BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies (Subject) Morrison Todd Hale (Filed by)
| Form SCHEDULE 13G | |
05/24/2024 3:45 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/24/2024 3:51 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
04/19/2024 3:38 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 424B3 | |
04/18/2024 11:15 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form EFFECT | |
04/12/2024 3:53 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form S-1/A | |
04/10/2024 4:16 PM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Silva Francisco (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 3:18 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/29/2024 5:15 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/29/2024 5:15 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/20/2024 3:38 PM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Silva Francisco (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 3:36 PM | ALSTODT LANCE (Reporting) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 6:30 AM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2024 3:34 PM | BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies (Subject) Broadrick Dale (Filed by)
| Form SC 13D/A | |
02/15/2024 3:43 PM | BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies (Subject) Silva Francisco (Filed by)
| Form SC 13D/A | |
02/15/2024 3:40 PM | ALSTODT LANCE (Filed by) BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies (Subject)
| Form SC 13D/A | |
02/15/2024 3:13 PM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Silva Francisco (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:17 PM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Kristal Robert Eugene (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:19 PM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Paccasassi Robert (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 12:44 PM | Auctus Fund Management LLC (Filed by) BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies, Inc. (Subject) BioRestorative Therapies (Subject)
| Form SC 13G/A | |
02/12/2024 8:26 AM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Broadrick Dale (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:00 AM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Broadrick Dale (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/08/2024 3:09 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 7:00 AM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/01/2024 3:43 PM | BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies, Inc. (Filer) BioRestorative Therapies (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 3:32 PM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Broadrick Dale (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/01/2023 4:04 PM | BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies, Inc. (Issuer) BioRestorative Therapies (Issuer) Broadrick Dale (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |